DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells

Ken-ichi Yamamoto, Hitoshi Murata, Endy Widya Putranto, Ken Kataoka, Akira Motoyama, Toshihiko Hibino, Yusuke Inoue, Masakiyo Sakaguchi, Nam Ho Huh

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Cellular migration is a fundamental process linked to cancer metastasis. Growing evidence indicates that the receptor for advanced glycation end products (RAGE) plays a pivotal role in this process. With regard to downstream signal transducers of RAGE, diaphanous-1 and activated small guanine nucleotide triphosphatases, Rac1 and Cdc42, have been identified. To obtain precise insight into the direct downstream signaling mechanism of RAGE, we screened for proteins interacting with the cytoplasmic domain of RAGE employing an immunoprecipitation-liquid chromatography coupled with an electrospray tandem mass spectrometry system. In the present study, we found that the cytoplasmic domain of RAGE interacted with an atypical DOCK180-related guanine nucleotide exchange factor, dedicator of cytokinesis protein 7 (DOCK7). DOCK7 bound to the RAGE cytoplasmic domain and transduced a signal to Cdc42, resulting in the formation of abundant highly branched filopodia-like protrusions, dendritic pseudopodia. Blocking of the function of DOCK7 greatly abrogated the formation of dendritic pseudopodia and suppressed cellular migration. These results indicate that DOCK7 functions as an essential and downstream regulator of RAGE-mediated cellular migration through the formation of dendritic pseudopodia.

Original languageEnglish
Pages (from-to)1073-1079
Number of pages7
JournalOncology Reports
Volume29
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Pseudopodia
Cytokinesis
Neoplasms
Proteins
Cytoplasmic and Nuclear Receptors
Guanine Nucleotide Exchange Factors
Guanine Nucleotides
Tandem Mass Spectrometry
Advanced Glycosylation End Product-Specific Receptor
Transducers
Immunoprecipitation
Liquid Chromatography
Neoplasm Metastasis

Keywords

  • Cdc42
  • Dedicator of cytokinesis protein 7
  • Filopodia
  • Migration
  • Receptor for advanced glycation end products

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells. / Yamamoto, Ken-ichi; Murata, Hitoshi; Putranto, Endy Widya; Kataoka, Ken; Motoyama, Akira; Hibino, Toshihiko; Inoue, Yusuke; Sakaguchi, Masakiyo; Huh, Nam Ho.

In: Oncology Reports, Vol. 29, No. 3, 03.2013, p. 1073-1079.

Research output: Contribution to journalArticle

Yamamoto, Ken-ichi ; Murata, Hitoshi ; Putranto, Endy Widya ; Kataoka, Ken ; Motoyama, Akira ; Hibino, Toshihiko ; Inoue, Yusuke ; Sakaguchi, Masakiyo ; Huh, Nam Ho. / DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells. In: Oncology Reports. 2013 ; Vol. 29, No. 3. pp. 1073-1079.
@article{b2c9e533f1254806b2ccbd34911fd3b4,
title = "DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells",
abstract = "Cellular migration is a fundamental process linked to cancer metastasis. Growing evidence indicates that the receptor for advanced glycation end products (RAGE) plays a pivotal role in this process. With regard to downstream signal transducers of RAGE, diaphanous-1 and activated small guanine nucleotide triphosphatases, Rac1 and Cdc42, have been identified. To obtain precise insight into the direct downstream signaling mechanism of RAGE, we screened for proteins interacting with the cytoplasmic domain of RAGE employing an immunoprecipitation-liquid chromatography coupled with an electrospray tandem mass spectrometry system. In the present study, we found that the cytoplasmic domain of RAGE interacted with an atypical DOCK180-related guanine nucleotide exchange factor, dedicator of cytokinesis protein 7 (DOCK7). DOCK7 bound to the RAGE cytoplasmic domain and transduced a signal to Cdc42, resulting in the formation of abundant highly branched filopodia-like protrusions, dendritic pseudopodia. Blocking of the function of DOCK7 greatly abrogated the formation of dendritic pseudopodia and suppressed cellular migration. These results indicate that DOCK7 functions as an essential and downstream regulator of RAGE-mediated cellular migration through the formation of dendritic pseudopodia.",
keywords = "Cdc42, Dedicator of cytokinesis protein 7, Filopodia, Migration, Receptor for advanced glycation end products",
author = "Ken-ichi Yamamoto and Hitoshi Murata and Putranto, {Endy Widya} and Ken Kataoka and Akira Motoyama and Toshihiko Hibino and Yusuke Inoue and Masakiyo Sakaguchi and Huh, {Nam Ho}",
year = "2013",
month = "3",
doi = "10.3892/or.2012.2191",
language = "English",
volume = "29",
pages = "1073--1079",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells

AU - Yamamoto, Ken-ichi

AU - Murata, Hitoshi

AU - Putranto, Endy Widya

AU - Kataoka, Ken

AU - Motoyama, Akira

AU - Hibino, Toshihiko

AU - Inoue, Yusuke

AU - Sakaguchi, Masakiyo

AU - Huh, Nam Ho

PY - 2013/3

Y1 - 2013/3

N2 - Cellular migration is a fundamental process linked to cancer metastasis. Growing evidence indicates that the receptor for advanced glycation end products (RAGE) plays a pivotal role in this process. With regard to downstream signal transducers of RAGE, diaphanous-1 and activated small guanine nucleotide triphosphatases, Rac1 and Cdc42, have been identified. To obtain precise insight into the direct downstream signaling mechanism of RAGE, we screened for proteins interacting with the cytoplasmic domain of RAGE employing an immunoprecipitation-liquid chromatography coupled with an electrospray tandem mass spectrometry system. In the present study, we found that the cytoplasmic domain of RAGE interacted with an atypical DOCK180-related guanine nucleotide exchange factor, dedicator of cytokinesis protein 7 (DOCK7). DOCK7 bound to the RAGE cytoplasmic domain and transduced a signal to Cdc42, resulting in the formation of abundant highly branched filopodia-like protrusions, dendritic pseudopodia. Blocking of the function of DOCK7 greatly abrogated the formation of dendritic pseudopodia and suppressed cellular migration. These results indicate that DOCK7 functions as an essential and downstream regulator of RAGE-mediated cellular migration through the formation of dendritic pseudopodia.

AB - Cellular migration is a fundamental process linked to cancer metastasis. Growing evidence indicates that the receptor for advanced glycation end products (RAGE) plays a pivotal role in this process. With regard to downstream signal transducers of RAGE, diaphanous-1 and activated small guanine nucleotide triphosphatases, Rac1 and Cdc42, have been identified. To obtain precise insight into the direct downstream signaling mechanism of RAGE, we screened for proteins interacting with the cytoplasmic domain of RAGE employing an immunoprecipitation-liquid chromatography coupled with an electrospray tandem mass spectrometry system. In the present study, we found that the cytoplasmic domain of RAGE interacted with an atypical DOCK180-related guanine nucleotide exchange factor, dedicator of cytokinesis protein 7 (DOCK7). DOCK7 bound to the RAGE cytoplasmic domain and transduced a signal to Cdc42, resulting in the formation of abundant highly branched filopodia-like protrusions, dendritic pseudopodia. Blocking of the function of DOCK7 greatly abrogated the formation of dendritic pseudopodia and suppressed cellular migration. These results indicate that DOCK7 functions as an essential and downstream regulator of RAGE-mediated cellular migration through the formation of dendritic pseudopodia.

KW - Cdc42

KW - Dedicator of cytokinesis protein 7

KW - Filopodia

KW - Migration

KW - Receptor for advanced glycation end products

UR - http://www.scopus.com/inward/record.url?scp=84872768774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872768774&partnerID=8YFLogxK

U2 - 10.3892/or.2012.2191

DO - 10.3892/or.2012.2191

M3 - Article

C2 - 23254359

AN - SCOPUS:84872768774

VL - 29

SP - 1073

EP - 1079

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 3

ER -